JP2009537606A5 - - Google Patents

Download PDF

Info

Publication number
JP2009537606A5
JP2009537606A5 JP2009511518A JP2009511518A JP2009537606A5 JP 2009537606 A5 JP2009537606 A5 JP 2009537606A5 JP 2009511518 A JP2009511518 A JP 2009511518A JP 2009511518 A JP2009511518 A JP 2009511518A JP 2009537606 A5 JP2009537606 A5 JP 2009537606A5
Authority
JP
Japan
Prior art keywords
lower alkyl
mono
phenyl
amino
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009511518A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009537606A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/055016 external-priority patent/WO2007137981A1/en
Publication of JP2009537606A publication Critical patent/JP2009537606A/ja
Publication of JP2009537606A5 publication Critical patent/JP2009537606A5/ja
Pending legal-status Critical Current

Links

JP2009511518A 2006-05-25 2007-05-23 チロシンキナーゼ阻害剤 Pending JP2009537606A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80318206P 2006-05-25 2006-05-25
PCT/EP2007/055016 WO2007137981A1 (en) 2006-05-25 2007-05-23 Inhibitors of tyrosine kinases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013096740A Division JP2013189443A (ja) 2006-05-25 2013-05-02 チロシンキナーゼ阻害剤

Publications (2)

Publication Number Publication Date
JP2009537606A JP2009537606A (ja) 2009-10-29
JP2009537606A5 true JP2009537606A5 (enExample) 2013-01-10

Family

ID=38255250

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009511518A Pending JP2009537606A (ja) 2006-05-25 2007-05-23 チロシンキナーゼ阻害剤
JP2013096740A Pending JP2013189443A (ja) 2006-05-25 2013-05-02 チロシンキナーゼ阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013096740A Pending JP2013189443A (ja) 2006-05-25 2013-05-02 チロシンキナーゼ阻害剤

Country Status (3)

Country Link
US (1) US8093259B2 (enExample)
JP (2) JP2009537606A (enExample)
WO (1) WO2007137981A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200840581A (en) * 2007-02-28 2008-10-16 Astrazeneca Ab Novel pyrimidine derivatives
TW201006823A (en) * 2008-07-14 2010-02-16 Novartis Ag Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis
US20140080772A1 (en) * 2012-09-06 2014-03-20 The Board Of Regents Of The University Of Texas System Treatments for melanoma
US20190343880A1 (en) * 2016-12-14 2019-11-14 Shinshu University Chimeric antigen receptor gene-modified lymphocyte having cytocidal effect
JP6944801B2 (ja) * 2017-03-29 2021-10-06 株式会社Ｓｃｒｅｅｎホールディングス ヒートローラおよびそれを備えた印刷装置
AU2019285066B2 (en) 2018-06-15 2024-06-13 Handa Pharmaceuticals, Inc. Kinase inhibitor salts and compositions thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516775A (en) * 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives
WO2002096927A2 (en) * 2001-05-29 2002-12-05 Ribozyme Pharmaceuticals, Incorporated Ribozyme based treatment of female reproductive diseases
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
KR20160014775A (ko) * 2003-05-30 2016-02-11 제넨테크, 인크. 항-ｖｅｇｆ 항체를 사용한 치료
DK1702917T3 (da) 2003-12-25 2017-11-13 Nippon Shinyaku Co Ltd Amidderivat og medicin
JP2008502738A (ja) * 2004-06-10 2008-01-31 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトの癌を処置するための、ｖｅｇｆインヒビターの使用
GB0425035D0 (en) * 2004-11-12 2004-12-15 Novartis Ag Organic compounds
CN101203224B (zh) * 2005-01-28 2010-11-03 诺瓦提斯公司 嘧啶基氨基苯甲酰胺在制备治疗对Tie-2激酶活性的调节有响应的疾病的药物中的用途

Similar Documents

Publication Publication Date Title
US20230116233A1 (en) Compounds And Compositions As Protein Kinase Inhibitors
JP2011530607A5 (enExample)
RU2315043C2 (ru) Амидное производное, фармацевтическая композиция и терапевтические средства на его основе
RU2012124811A (ru) СПОСОБ ЛЕЧЕНИЯ ПРОЛИФЕРАТИВНЫХ НАРУШЕНИЙ И ДРУГИХ ПАТОЛОГИЧЕСКИХ СОСТОЯНИЙ, ОПОСРЕДОВАННЫХ АКТИВНОСТЬЮ КИНАЗ Bcr-Abl, c-Kit, DDR1, DDR2, ИЛИ PDGF-R
JP2020503299A5 (enExample)
JP2016514718A5 (enExample)
JP2008528467A5 (enExample)
RU2018131775A (ru) 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета
RU2012120901A (ru) Способ лечения пролиферативных расстройств и других патологических состояний, опосредованных действием киназ bcr-abl, c-kit, ddr1, ddr2 или pdgf-r
WO2012000304A1 (zh) 杂环炔苯类化合物及其药用组合物和应用
JP2017535589A (ja) ２−アミノピリミジン系化合物およびその薬物組成物と使用
US20130096149A1 (en) Heteroaryl compounds and compositions as protein kinase inhibitors
JP2019505595A5 (enExample)
JP2019505594A5 (enExample)
RU2018131766A (ru) 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета
RU2012147511A (ru) Применение ингибиторов c-src в комбинации с пиримидиламинобензамидом для лечения лейкоза
RU2011109078A (ru) Лечение легочной артериальной гипертензии
JP2009537606A5 (enExample)
CA2617991A1 (en) N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
JP2017536342A5 (enExample)
RU2011105059A (ru) Применение производных пиримидиламинобензамида для лечения фиброза
US20250188075A1 (en) Substituted heterocyclic csnk1 inhibitors
RU2008127264A (ru) Производные пиримидиламинобензамида, предназначенные для лечения нейрофиброматоза
RU2007132255A (ru) Применение пиримидиламинобензамидов для лечения заболеваний, чувствительных к модуляции активности киназы tie-2
JP2020531485A5 (enExample)